An anonymous investor intercepted the following transcript
An anonymous investor intercepted the following transcript of the weekly Paid Basher conference call. The following is heavily encrypted to protect the paid basher’s identities but clearly states their talking points for the coming week. I haven’t yet vetted its authenticity.
=================================================
“This last week has been difficult with IPIX’s damn CEO surprising us once again with a PR of a Term sheet for what was supposed to be their second instance of Brilacidin. This was as much of a surprise to us as that damn European Subsidiary PR out of nowhere. We are upside down on this damn little stock and we need shares. Your job is to shake loose whatever shares you can get. Time is of the essence as there could be a PR out any day now that will name the Global Pharma and will blow away most of our false narratives of funding, dilution, management execution, science validation and market value. New investors will flood in and we will be F****ed! I realize that some of you have had a decrease in commissions with no one replying to your posts if you are on that damn Kelt’s “swindlers list”. We take care of our own so we will double your price per post from 10 to 20 cents. This should keep you in the upper echelon of income in your shithole countr….err remote locations. That damn Drano keeps taking down our posts where we flat out lie and attack long term investors. What kind of BS message board is this anyways? That 4kids poster I swear is from a different planet and has been tracking every move we make and now half the damn board is knows what we are doing. This week’s assignments are as follows:
trrol and FloppyhatCA- You two keep up on our secret Operation Toss Salad. Keep up the mouth to anus narrative, stop all that giggling, this is serious! The investors for some reason aren’t buying this narrative even though Wikipedia says so. These investors are actually reading the IPIX PR’s and we are so screwed if they kick off a phase3 for B-OM soon with ample funding from 1 or maybe 2 large license deals. Anyways keep pretending you have a zillion shares and turn up the FUD that no one is interested in B-OM or really anything IPIX has in their portfolio.
YellowfruitFeline – Continue to use your math skills. When someone talks about the market size divide by 3. When they talk license revenue divide by 3. When you end up with a number divide by 2 again. Take the lessor of that number or just use $1 or $2 per share best case. Tell them how lucky they would be to get a 4X from today’s SP. Remember we need some of these fools to put in GTC orders under $3 so that we can pick them off when this damn stock takes off. We need REAL shares!
JudasStockings- Just keep coming up with new aliases and see if any of them stick. Maybe a Doctor or Bio Chemist. Use your imagination and act insulted if they call you out. You can have a zillion shares as well but don’t get trapped into admitting who your past aliases were.
Whiny Operative- Continue to post that you are OK with dilution but cut and paste blather from the financials from the MFO funding and maybe some Aspire FUD. Ignore the fact that this company has minimal dilution entering into a phase 3. Flood the board and continue to make friends.
HeadLice/NoSurrender – Keep attacking the NSS exposers. Call NSS the bogeyman, and accuse the real investors of doing what we are doing. It doesn’t work very well but it really disrupts this stupid board with their rules and such.
The rest of you remember to turn up the heat. Lie, contradict, start arguments with real investors and even each other to disrupt this board. Reiterate how lucky these SOB’s will be if they can get out with a dollar or 2. Time is our enemy.”
9
1
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Popping Corks for Creativity: Decoy's New Chapter Stepping outside the vines and into the artistic limelight, Decoy Wines is shaking up the status quo. Announcing the launch of the Pour to What's Possible Grant, the brand is throwing down $10,000 to back creatives itching to make waves in entertainment. Now, doesn't that stand out? The Grit Behind the Grapes: Decoy's...
Continue Reading
Revving Up for Major Investor Conferences All eyes are on TETRA Technologies Inc. (NYSE:TTI) as they gear up to make splashy appearances at not one, but two high-profile investor conferences in New York. It's setting the stage for some potentially juicy conversations about where TTI, a player with deep roots in energy services, is heading in this whirlwind of an industry....
Continue Reading
Testing the Waters with Education Stake Talk about mixing oil and water. Scienjoy Holding Corporation, those tech-savvy folks from China's live streaming circles, have set their sights on education with a hefty 29.9% stake in Leader Education Limited. For HK$102.69 million, that’s about US$13.1 million, they’re jumping into an industry with a different flavor....
Continue Reading
Revamping Streetwear with PLAY Palm Angels and Pacsun In a move that's making waves from the fashion runways straight into the heart of youth culture, PLAY Palm Angels is swooping into Pacsun, and they’re not just strolling in—they’re parading with a 41-piece fashion collection. Not to mention, they've snagged Avani Gregg, a powerhouse cultural influencer, to strut...
Continue Reading
Another Day, Another Lawsuit: Hims & Hers in Hot Water Here's the latest conundrum in the corporate world, folks. Hims & Hers Health, Inc. (NYSE: HIMS) is caught up in a class action lawsuit that could shake up the telehealth scene. Investors who found themselves knee-deep in losses during the class period from August 2025 to July 2026 might want to pay attention. The...
Continue Reading
Robo.ai's Financial Rocket Lift-off: Q2 Highlights Who would've thought a single acquisition could propel a company's revenue north of $180 million in just three months? Well, Robo.ai, with its recent grab of Quantum Core Capital (QC Capital), shattered that ceiling, showcasing what a savvy acquisition and a dash of tech wizardry can achieve. Strong Quarter, Stronger...
Continue Reading
Driving AI Adoption: A Shift Towards Human-Centric Learning McLean & Company has dropped an initiative that’s like laying fresh tracks for AI inclusion in businesses. Dubbed the Human-Centric AI Program, it’s a wake-up call to organizations struggling to shift AI from a novelty to a natural part of operations. This isn’t just about fiddling with AI tools; it’s...
Continue Reading
Financial Stress — The Silent Productivity Killer Down in the trenches of nine-to-five, it’s money that keeps stealing workers' peace of mind. The TELUS Mental Health Index shines a glaring spotlight on this, revealing that 58% of U.S. workers are most stressed by living costs. Now, that's a kicker when stacking it next to retirement or emergency savings. Those take...
Continue Reading
Kroger Welcomes a Seasoned Retail Veteran Change often arrives with the dawn of new leadership. As Kroger takes a page from the playbook of large-scale retail transformation, they've enlisted Mark Ibbotson. Effective September 14, Ibbotson will step in as Executive Vice President and Chief Store Operations Officer. It's a roll of the dice that could either accelerate...
Continue Reading
Undercover Investigation Shakes Up York University If you thought the world of research was all about sterile labs and the pursuit of knowledge, think again. The Jane Goodall Institute (JGI), famed for championing animal welfare, has urged York University to let go of nine long-suffering rhesus macaques. Turns out, these macaques weren't exactly living their best lives....
Continue Reading
Top 5 Most Recently Viewed Articles
Understanding Stock Market Dynamics The stock market is often seen as a single entity, but it actually encompasses a wide array of companies, each with its own story and potential for growth. When evaluating the market, it's important to remember that even if major indices are at peak levels, individual stocks can still provide compelling investment opportunities....
Continue Reading
Mogo's Financial Growth in Q3 2024 Mogo Inc. (NASDAQ:MOGO) has recently reported its financial and operational achievements for the third quarter, showcasing substantial advances in its digital wealth and payments sectors. The company has diligently pursued sustainable profitability, a priority that has considerably influenced its performance metrics. Key Financial...
Continue Reading
Understanding Recent Changes in JPMorgan Chase's Short Interest JPMorgan Chase (JPM) has seen a notable rise in its short percent of float, increasing by 7.77% from the last report. The recent data shows that 31.01 million shares have been sold short, which accounts for about 1.11% of all actively traded shares. Given the trading conditions, it appears that traders would...
Continue Reading
XPENG's Journey in the Third Quarter of 2024 XPeng Inc. (“XPENG” or “the Company,” NYSE: XPEV and HKEX: 9868) recently disclosed its financial results for the third quarter ended September 30, 2024. This marks a significant period showcasing growth in revenues and vehicle deliveries, reflecting the company's robust strategy in the smart electric vehicle market....
Continue Reading
Ashford Trust Dividend Announcements for Preferred Stockholders Ashford Hospitality Trust, Inc. (NYSE: AHT) is making significant moves to reward its investors with attractive dividends. The Board of Directors has officially declared a series of dividends for the fourth quarter of this financial year. This reflects the company's solid performance and commitment to its...
Continue Reading